Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid‐induced osteonecrosis of the femoral headNing Yang, Dechun Geng|Clinical and Translational Medicine|2021Cited by 82
Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis ResistanceJie Yang, Qi Shen, Jun Zhang et al.|Advanced Healthcare Materials|2022Cited by 70